Krsnaa Diagnostics reported a consolidated net profit of Rs 24.59 crore for Q2 FY27, up from Rs 23.95 crore in the same period last year. Revenue saw a strong 31.5% year-on-year growth to Rs 270.97 crore. Investors are advised to track a tax litigation case involving a Rs 62.69 crore demand, for which the company has deposited Rs 10.28 crore under protest.
Krsnaa Diagnostics Reports 31% Revenue Growth in Q2 FY27
Revenue from operations stood at Rs 270.97 crore; Consolidated net profit reached Rs 24.59 crore.
Reader Takeaway: Strong top-line growth is tempered by rising operating expenses and a pending Rs 62.69 crore tax demand.
What just happened
Krsnaa Diagnostics Limited released its unaudited financial results for the second quarter ending September 30, 2026. The company posted a consolidated revenue of Rs 270.97 crore, representing a robust 31.5% growth compared to Rs 205.99 crore in the corresponding quarter of the previous fiscal year. Net profit improved marginally to Rs 24.59 crore from Rs 23.95 crore, amid a significant rise in total quarterly expenses.
Why this matters
The company is scaling its diagnostic operations effectively, as evidenced by double-digit revenue growth. However, profitability has not kept pace with the top-line expansion due to higher operational costs, including increased employee benefits and hospital fees.
Legal and Tax Update
The company is currently contesting tax demands totaling Rs 62.69 crore (Rs 626.90 million) arising from search assessment proceedings under the Income Tax Act for the assessment years 2017-18 to 2023-24. Krsnaa Diagnostics has already deposited Rs 10.28 crore under protest and is preparing to file appeals with the Income Tax Appellate Tribunal (ITAT). Management maintains that these tax demands are not tenable and are not expected to have a material adverse impact on the company's overall financial position.
Risks to watch
Investors should monitor the progression of the tax litigation at the ITAT level. Additionally, the trend of rising operating expenses relative to revenue growth warrants close observation, as it could continue to exert pressure on bottom-line margins in upcoming quarters.
What to track next
Watch for further disclosures regarding the ITAT appeal outcomes and the management's efforts to control rising overheads to ensure that revenue gains successfully translate into higher net profits.